Search results
Results from the WOW.Com Content Network
Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako, broad product portfolio and solid international growth. However, pricing pressure raises concern.
Stryker's (SYK) third-quarter results are likely to reflect strong segmental performances. ... News. 24/7 help. For premium support please call: 800-290-4726 more ways to reach us. Login / Join.
Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises concern.
Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on it.
For premium support please call: 800-290-4726 more ways to reach us
In 1964, the company name was changed to Stryker Corporation. [6] In 1979, Stryker made an initial public offering of stock and later acquired Osteonics Corporation, entering the replacement hip, knee, and other orthopedic implants market (Stryker). In 1999 annual sales reached $2.1 billion, and in 2000 Stryker was included in the S&P 500 and ...
Most readers would already know that Stryker's (NYSE:SYK) stock increased by 4.9% over the past week. Given that the...
Today we're going to take a look at the well-established Stryker Corporation ( NYSE:SYK ). The company's stock saw a...